{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:43:23Z","timestamp":1793223803258,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41388-019-0747-0","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T08:17:08Z","timestamp":1549873028000},"page":"4637-4654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":256,"title":["MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer"],"prefix":"10.1038","volume":"38","author":[{"given":"Wanming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-0610","authenticated-orcid":false,"given":"Zexian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"747_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"747_CR2","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3748\/wjg.v22.i8.2403","volume":"22","author":"A Digklia","year":"2016","unstructured":"Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22:2403\u201314.","journal-title":"World J Gastroenterol"},{"key":"747_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clcc.2015.05.013","volume":"14","author":"M Davidson","year":"2015","unstructured":"Davidson M, Okines AF, Starling N. Current and future therapies for advanced gastric cancer. Clin Colorectal Cancer. 2015;14:239\u201350.","journal-title":"Clin Colorectal Cancer"},{"key":"747_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","volume":"14","author":"JA Ajani","year":"2016","unstructured":"Ajani JA, D\u2019Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:1286\u2013312.","journal-title":"J Natl Compr Canc Netw"},{"key":"747_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10120-016-0648-7","volume":"20","author":"K Shitara","year":"2017","unstructured":"Shitara K. Chemotherapy for advanced gastric cancer: future perspective in Japan. Gastric Cancer. 2017;20:102\u201310.","journal-title":"Gastric Cancer"},{"key":"747_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/14737140.2016.1184979","volume":"16","author":"M Roberto","year":"2016","unstructured":"Roberto M, Romiti A, Onesti CE, Zullo A, Falcone R, Marchetti P. Evolving treatments for advanced gastric cancer: appraisal of the survival trend. Expert Rev Anticancer Ther. 2016;16:717\u201329.","journal-title":"Expert Rev Anticancer Ther"},{"key":"747_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ccr.2011.08.010","volume":"20","author":"JM Roodhart","year":"2011","unstructured":"Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM, et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell. 2011;20:370\u201383.","journal-title":"Cancer Cell"},{"key":"747_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/bjc.2012.201","volume":"106","author":"JM Houthuijzen","year":"2012","unstructured":"Houthuijzen JM, Daenen LG, Roodhart JM, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br J Cancer. 2012;106:1901\u20136.","journal-title":"Br J Cancer"},{"key":"747_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/2159-8290.CD-12-0101","volume":"2","author":"HJ Li","year":"2012","unstructured":"Li HJ, Reinhardt F, Herschman HR, Weinberg RA. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2012;2:840\u201355.","journal-title":"Cancer Discov"},{"key":"747_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227\u201332.","journal-title":"Nat Rev Cancer"},{"key":"747_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.cmet.2018.04.018","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, et al. JAK\/STAT3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 2018;27:1357.","journal-title":"Cell Metab"},{"key":"747_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011;1807:726\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"747_CR13","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.2882","volume":"18","author":"K Ito","year":"2012","unstructured":"Ito K, Carracedo A, Weiss D, Arai F, Ala U, Avigan DE, et al. A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med. 2012;18:1350\u20138.","journal-title":"Nat Med"},{"key":"747_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nature10887","volume":"482","author":"M Guttman","year":"2012","unstructured":"Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482:339\u201346.","journal-title":"Nature"},{"key":"747_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41419-018-0706-7","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu B, Ma X, Liu Q, Xiao Y, Pan S, Jia L. Aberrant mannosylation profile and FTX\/miR-342\/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia. Cell Death Dis. 2018;9:688.","journal-title":"Cell Death Dis"},{"key":"747_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/hep.27893","volume":"63","author":"SX Yuan","year":"2016","unstructured":"Yuan SX, Wang J, Yang F, Tao QF, Zhang J, Wang LL, et al. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology. 2016;63:499\u2013511.","journal-title":"Hepatology"},{"key":"747_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.stem.2015.03.003","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;16:413\u201325.","journal-title":"Cell Stem Cell"},{"key":"747_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0820-2","volume":"17","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang S, et al. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK\/Lin28 mediated mRNA stability of MACC1. Mol Cancer. 2018;17:69.","journal-title":"Mol Cancer"},{"key":"747_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780\u20133.","journal-title":"Nature"},{"key":"747_CR20","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/jcp.25318","volume":"231","author":"AM Francesco Di","year":"2016","unstructured":"Di Francesco AM, Toesca A, Cenciarelli C, Giordano A, Gasbarrini A, Puglisi MA. Metabolic modification in gastrointestinal cancer stem cells: characteristics and therapeutic approaches. J Cell Physiol. 2016;231:2081\u20137.","journal-title":"J Cell Physiol"},{"key":"747_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16:79.","journal-title":"Mol Cancer"},{"key":"747_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347:70\u201378.","journal-title":"J Immunol Methods"},{"key":"747_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","volume":"7","author":"T Simsek","year":"2010","unstructured":"Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI, Olson EN, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7:380\u201390.","journal-title":"Cell Stem Cell"},{"key":"747_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nature09572","volume":"468","author":"S Gurumurthy","year":"2010","unstructured":"Gurumurthy S, Xie SZ, Alagesan B, Kim J, Yusuf RZ, Saez B, et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature. 2010;468:659\u201363.","journal-title":"Nature"},{"key":"747_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nature09571","volume":"468","author":"D Nakada","year":"2010","unstructured":"Nakada D, Saunders TL, Morrison SJ. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature. 2010;468:653\u20138.","journal-title":"Nature"},{"key":"747_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest. 2010;120:142\u201356.","journal-title":"J Clin Invest"},{"key":"747_CR27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup M, Novitskiy S, Moses HL. The roles of TGFbeta in the tumour microenvironment. Nat Rev Cancer. 2013;13:788\u201399.","journal-title":"Nat Rev Cancer"},{"key":"747_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","volume":"15","author":"S Penuelas","year":"2009","unstructured":"Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I, et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 2009;15:315\u201327.","journal-title":"Cancer Cell"},{"key":"747_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463:676\u201380.","journal-title":"Nature"},{"key":"747_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.molcel.2007.11.039","volume":"29","author":"J Groppe","year":"2008","unstructured":"Groppe J, Hinck CS, Samavarchi-Tehrani P, Zubieta C, Schuermann JP, Taylor AB, et al. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell. 2008;29:157\u201368.","journal-title":"Mol Cell"},{"key":"747_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685\u2013700.","journal-title":"Cell"},{"key":"747_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J. TGFbeta in cancer. Cell. 2008;134:215\u201330.","journal-title":"Cell"},{"key":"747_CR33","doi-asserted-by":"publisher","first-page":"10553","DOI":"10.1007\/s13277-016-4957-6","volume":"37","author":"M Zhan","year":"2016","unstructured":"Zhan M, Zhao X, Wang H, Chen W, Xu S, Wang W, et al. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1. Tumour Biol. 2016;37:10553\u201362.","journal-title":"Tumour Biol"},{"key":"747_CR34","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1007\/s13277-015-3152-5","volume":"36","author":"RL Liu","year":"2015","unstructured":"Liu RL, Dong Y, Deng YZ, Wang WJ, Li WD. Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer. Tumour Biol. 2015;36:5011\u20139.","journal-title":"Tumour Biol"},{"key":"747_CR35","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1128\/MCB.00042-14","volume":"34","author":"YY Lin","year":"2014","unstructured":"Lin YY, Chou CF, Giovarelli M, Briata P, Gherzi R, Chen CY. KSRP and MicroRNA 145 are negative regulators of lipolysis in white adipose tissue. Mol Cell Biol. 2014;34:2339\u201349.","journal-title":"Mol Cell Biol"},{"key":"747_CR36","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jcp.25499","volume":"232","author":"H Wang","year":"2017","unstructured":"Wang H, Shi H, Luo J, Yi Y, Yao D, Zhang X, et al. MiR-145 regulates lipogenesis in goat mammary cells via targeting INSIG1 and epigenetic regulation of lipid-related genes. J Cell Physiol. 2017;232:1030\u201340.","journal-title":"J Cell Physiol"},{"key":"747_CR37","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-07-2223","volume":"14","author":"MB Meads","year":"2008","unstructured":"Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14:2519\u201326.","journal-title":"Clin Cancer Res"},{"key":"747_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbalip.2016.08.011","volume":"1862","author":"AJ Kastaniotis","year":"2017","unstructured":"Kastaniotis AJ, Autio KJ, Keratar JM, Monteuuis G, Makela AM, Nair RR, et al. Mitochondrial fatty acid synthesis, fatty acids and mitochondrial physiology. Biochim Biophys Acta. 2017;1862:39\u201348.","journal-title":"Biochim Biophys Acta"},{"key":"747_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","volume":"34","author":"M Graversen","year":"2017","unstructured":"Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. 2017;34:309\u201314.","journal-title":"Clin Exp Metastasis"},{"key":"747_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbagen.2009.09.001","volume":"1800","author":"CT Chen","year":"2010","unstructured":"Chen CT, Hsu SH, Wei YH. Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. Biochim Biophys Acta. 2010;1800:257\u201363.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 3","key":"747_CR41","doi-asserted-by":"publisher","first-page":"S539","DOI":"10.1245\/s10434-011-2040-5","volume":"19","author":"HM Kim","year":"2012","unstructured":"Kim HM, Haraguchi N, Ishii H, Ohkuma M, Okano M, Mimori K, et al. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon. Ann Surg Oncol. 2012;19(Suppl 3):S539\u2013548.","journal-title":"Ann Surg Oncol"},{"key":"747_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3109\/07357907.2012.692171","volume":"30","author":"H Ye","year":"2012","unstructured":"Ye H, Cheng J, Tang Y, Liu Z, Xu C, Liu Y, et al. Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer. Cancer Invest. 2012;30:513\u20138.","journal-title":"Cancer Invest"},{"key":"747_CR43","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3727\/096368912X657954","volume":"22","author":"SP Hung","year":"2013","unstructured":"Hung SP, Yang MH, Tseng KF, Lee OK. Hypoxia-induced secretion of TGF-beta1 in mesenchymal stem cell promotes breast cancer cell progression. Cell Transplant. 2013;22:1869\u201382.","journal-title":"Cell Transplant"},{"key":"747_CR44","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1016\/j.jmb.2013.02.030","volume":"425","author":"IV Novikova","year":"2013","unstructured":"Novikova IV, Hennelly SP, Tung CS, Sanbonmatsu KY. Rise of the RNA machines: exploring the structure of long non-coding RNAs. J Mol Biol. 2013;425:3731\u201346.","journal-title":"J Mol Biol"},{"key":"747_CR45","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904\u201314.","journal-title":"Mol Cell"},{"key":"747_CR46","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00109-009-0518-4","volume":"87","author":"L Ricci-Vitiani","year":"2009","unstructured":"Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R. Colon cancer stem cells. J Mol Med (Berl). 2009;87:1097\u2013104.","journal-title":"J Mol Med (Berl)"},{"key":"747_CR47","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/neuonc\/nov298","volume":"18","author":"Z Xu","year":"2016","unstructured":"Xu Z, Zeng X, Xu J, Xu D, Li J, Jin H, et al. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145\/SOX2\/cyclin D1 axis. Neuro Oncol. 2016;18:830\u20139.","journal-title":"Neuro Oncol"},{"key":"747_CR48","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","volume":"17","author":"K Washington","year":"2010","unstructured":"Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077\u20139.","journal-title":"Ann Surg Oncol"},{"key":"747_CR49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","volume":"19","author":"S Hao","year":"2017","unstructured":"Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B, et al. Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells. Neoplasia. 2017;19:1022\u201332.","journal-title":"Neoplasia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0747-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0747-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0747-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:15:40Z","timestamp":1684602940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-0747-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":49,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-0747-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"8 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}